Top Researchers
Top Medicine Researchers at University of Alabama at Birmingham for 2026
Research at the University of Alabama at Birmingham continues to span the breadth of Medicine, with activity ranging from kidney care and cancer studies to surgery, pulmonary medicine, and population health. The work below reflects a broad clinical research community that is both patient-centered and methodologically diverse.
Across the last year, these researchers have published on care delivery, treatment response, survivor outcomes, and specialty training, showing how medicine at UAB connects bedside questions with practical evidence for clinicians and patients.
Featured Researchers
Javier A. Neyra
Javier A. Neyra’s recent work at the University of Alabama at Birmingham centers on nephrology and critical care, with studies on sepsis-associated acute kidney injury, methotrexate toxicity, and machine learning for kidney injury risk classification.
Activity over the last year: 44 indexed journal articles.
Top publications:
- Epidemiology of sepsis-associated acute kidney injury in the ICU with contemporary consensus definitions (Mar 2025)
- Glucarpidase for treatment of high-dose methotrexate toxicity (Jan 2025)
- Systematic Review and Meta-Analysis of Machine Learning Models for Acute Kidney Injury Risk Classification (Mar 2025)
Gabrielle B. Rocque
Gabrielle B. Rocque has focused on oncology and public health questions at the University of Alabama at Birmingham, including financial toxicity, remote symptom monitoring, and prediction of response in HER2-positive breast cancer.
Activity over the last year: 39 indexed journal articles.
Top publications:
- Social and Legal Needs in Patients and Families With Cancer: Interaction With Patient-Level Financial Toxicity (Jan 2025)
- Remote Symptom Monitoring With Electronic Patient-Reported Outcomes in Clinical Cancer Populations (May 2025)
- Predicting pathologic complete response (pCR) from clinicopathologic variables and HER2DX genomic test in stage II/III HER2+ breast cancer treated with taxane, trastuzumab, and pertuzumab (THP): Secondary results from the EA1181/CompassHER2 pCR trial. (May 2025)
Herbert Chen
Herbert Chen’s recent publications at the University of Alabama at Birmingham span surgery, endocrine care, and training equity, from parathyroidectomy outcomes to surgical journal representation and pipeline programs.
Activity over the last year: 37 indexed journal articles.
Top publications:
- Representation of Women as Editors of the Top Surgery Journals in the World (Jul 2025)
- Changes in Bone Mineral Density After Parathyroidectomy in Patients With Primary Hyperparathyroidism (Jan 2025)
- The impact of surgical research pipeline programs on underrepresented minority high school and undergraduate students’ career development (Oct 2025)
Brenessa Lindeman
Brenessa Lindeman’s work at the University of Alabama at Birmingham links surgery with nephrology and gender-focused scholarship, including hyperparathyroidism comparisons, surgical education frameworks, and resident feedback.
Activity over the last year: 44 indexed journal articles.
Top publications:
- Patients with normocalcemic versus hypercalcemic hyperparathyroidism: What's really the difference? (Feb 2025)
- Research Agenda for Entrustable Professional Activities Among US Surgical Specialties (Jan 2025)
- Feedback Perceived by General Surgery Residents: What is the Influence of Program Characteristics? (Apr 2025)
Rebecca C. Arend
Rebecca C. Arend’s recent output at the University of Alabama at Birmingham emphasizes reproductive medicine, gynecologic oncology, and clinical guidance, including uterine and cervical cancer guidelines and a phase III cervical and vaginal cancer trial.
Activity over the last year: 44 indexed journal articles.
Top publications:
- NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025 (Aug 2025)
- Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology (Dec 2025)
- Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial (Mar 2025)
Pankit Vachhani
Pankit Vachhani’s University of Alabama at Birmingham publications focus on hematology and genetics, with recent work on chronic myeloid leukemia remission, myelofibrosis treatment choices, and patient-reported outcomes in acute lymphoblastic leukemia.
Activity over the last year: 42 indexed journal articles.
Top publications:
- Real-World Evidence of Treatment-Free Remission Strategies and Outcomes in Chronic Myeloid Leukemia (Jun 2025)
- JAK inhibitor selection in challenging scenarios of myelofibrosis: a review (Nov 2025)
- Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial (Apr 2025)
Smita Bhatia
Smita Bhatia’s recent studies at the University of Alabama at Birmingham bring together pediatrics, public health, and survivorship research, including long-term follow-up guidance for childhood cancer survivors and barriers to foregut cancer care.
Activity over the last year: 36 indexed journal articles.
Top publications:
- The Children’s Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers (Feb 2025)
- Patient-Reported Barriers to Foregut Cancer Care in the Deep South (Mar 2025)
- Contributions of cancer treatment and genetic predisposition to risk of subsequent neoplasms in long-term survivors of childhood cancer: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study (May 2025)
Surya P. Bhatt
Surya P. Bhatt’s recent work at the University of Alabama at Birmingham focuses on pulmonary medicine and physiology, especially dupilumab in COPD, biomarker-guided response, and imaging-based assessment of small airway disease.
Activity over the last year: 35 indexed journal articles.
Top publications:
- Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials (Jan 2025)
- Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial (Jul 2025)
- Deep Learning Estimation of Small Airway Disease from Inspiratory Chest Computed Tomography: Clinical Validation, Repeatability, and Associations with Adverse Clinical Outcomes in Chronic Obstructive Pulmonary Disease (Mar 2025)
What University of Alabama at Birmingham's Medicine Community Is Working On
The most common subfields point to a community actively working at the intersection of nephrology, public health, oncology, and surgery. That mix suggests a strong emphasis on chronic disease management, cancer care, and the systems that shape outcomes, alongside ongoing attention to clinical training and care delivery. Critical care, pulmonary medicine, hematology, pediatrics, and endocrine topics also appear, reinforcing the breadth of medical research being pursued across the University of Alabama at Birmingham.- Nephrology - seen across 3 of the featured researchers
- Public Health, Environmental and Occupational Health - seen across 3 of the featured researchers
- Oncology - seen across 2 of the featured researchers
- Surgery - seen across 2 of the featured researchers
- Critical Care and Intensive Care Medicine - seen across 1 of the featured researchers
Together, these publications offer a useful snapshot of how medical research at the University of Alabama at Birmingham is shaping everyday care, training, and long-term outcomes across specialties. If you want to stay organized while tracking literature, preparing manuscripts, or managing submissions, Resub can help streamline the workflow behind the research.
Top researchers use tools to scale their productivity and impact. Try Livewrite for free today.